In contrast, high-expressed COMMD7 was associated with Wnt, RAS, MAPK, and Hedgehog pathways, suggesting that COMMD7 was not only a potential prognostic biomarker but also a promising therapeutic target by affecting oncogenesis-related pathways in AML. Here, COMMD7 is linked to acute myeloid leukemia.